Skip to main content
. 2017 Nov 9;15(1):998–1006. doi: 10.3892/ol.2017.7386

Figure 4.

Figure 4.

Kaplan-Meier survival analysis in 95 patients of WHO II–IV grade gliomas, according to the CD163 immunohistochemical expression. (A) Correlation of OS with CD163 levels according to a four-category (0, 1, 2, 3) scoring system. (B) Correlation of OS with CD163 levels according to a two-category (low and high) scoring system. The log-rank test was performed to determine statistical significance, with P<0.05 considered as significant. OS, overall survival; CD, cluster of differentiation; WHO, World Health Organization.